查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1666164

全球套管针市场 - 2025 至 2033 年

Global Trocars Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球套管针市场规模达到 8.1233 亿美元，预计到 2033 年将达到 14.1787 亿美元，2025-2033 年预测期内的复合年增长率为 6.4%。

套管针是一种在各种医疗过程中用于进入体腔的手术工具。套管针最常用于腹腔镜或微创手术，这些手术通常会采用较小的切口来减少恢復时间、减少疤痕并降低感染风险。这些工具对于腹腔镜检查、关节镜检查和某些类型的内视镜检查等手术至关重要，因为它们使医生能够以最小的身体干扰执行复杂的手术。

它通常由锋利的尖头装置（通常是钢）製成，连接到空管或套管。这使得外科医生能够安全地穿刺身体组织，为将其他工具（例如相机或手术器械）插入体内提供通道。

市场动态：

驱动因素与约束因素

慢性病盛行率上升

糖尿病、癌症、心臟病、中风、胃肠道疾病、肝病和肥胖症等慢性疾病的发生率不断上升，是套管针市场发展的重要驱动力。这些情况通常需要手术干预，对套管针的需求更高，套管针是腹腔镜检查等微创手术中不可或缺的工具。

套管针通常用于治疗各种慢性疾病相关併发症的手术。在慢性阻塞性肺病 (COPD) 中，套管针可用于胸腔镜检查期间进行肺减容术或肺移植等手术。在慢性肾臟病 (CKD) 中，套管针可协助进行微创肾臟移植或肾臟切除。例如，根据美国肺臟协会 2024 年的数据，COPD 影响美国约 1,170 万成年人，每年导致数十万人次急诊就诊，医疗费用估计达 500 亿美元。 COPD 包括慢性支气管炎和肺气肿等疾病。 2022 年，美国 4.6% 的成年人被诊断出患有 COPD。

此外，老年人口的增加使得他们更容易患上慢性疾病，预计这也将推动对外科手术的需求，从而扩大套管针市场。

併发症风险

预计与套管针使用相关的併发症风险将成为套管针市场发展的重大限制因素。儘管套管针的设计是安全的，但使用或放置不当可能会导致周围组织（如血管、器官或神经）受伤。这些併发症可能导致额外的手术程序、更长的恢復时间和更高的医疗费用，所有这些都可能阻止医院和外科医生采用或增加套管针的使用。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 慢性病盛行率上升
    • 限制
      • 併发症风险
    • 机会
  • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：依产品类型

  • 无刀片套管针
  • 刀片套管针
  • 一次使用套管针
  • 可重复使用套管针
  • 光学套管针
  • 钝套管针
  • 其他的

第 7 章：按应用

  • 一般外科
  • 妇科手术
  • 泌尿科
  • 小儿外科
  • 其他的

第 8 章：按最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第九章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Conmed Corporation
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • The Cooper Companies Inc
  • Teleflex Incorporated
  • Medtronic Plc
  • B. Braun Medical Inc
  • JOHNSON & JOHNSON
  • Laprosurge
  • Purple Surgical
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Peters Surgical
  • Similar data will be provided for each market player.

第 12 章：附录

简介目录
Product Code: PH1315

The global trocars market reached US$ 812.33 million in 2024 and is expected to reach US$ 1,417.87 million by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033.

A trocar is a surgical tool used to create access to body cavities during various medical procedures. Trocars are most commonly used in laparoscopic or minimally invasive surgeries, where smaller incisions are preferred to reduce recovery time, minimize scarring, and decrease the risk of infection. These tools are crucial in surgeries like laparoscopy, arthroscopy, and certain types of endoscopy, as they enable doctors to perform complex procedures with minimal disruption to the body.

It's typically made of a sharp, pointed device, often steel, which is attached to a hollow tube or cannula. This allows surgeons to puncture the body's tissue safely, providing a pathway for inserting other tools, such as cameras or surgical instruments, into the body.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, such as diabetes, cancer, heart disease, stroke, gastrointestinal disorders, liver illnesses, and obesity, is a significant driver for the trocars market. These conditions often necessitate surgical interventions, leading to a higher demand for trocars, which are essential tools in minimally invasive procedures like laparoscopy.

Trocars are commonly used in surgeries that address complications associated with various chronic diseases. In chronic obstructive pulmonary disease (COPD), trocars can be used during thoracoscopy for procedures like lung volume reduction or lung transplantation. In chronic kidney disease (CKD), trocars assist in minimally invasive kidney transplants or nephrectomies. For instance, according to the American Lung Association in 2024, COPD affects approximately 11.7 million adults in the United States and results in hundreds of thousands of emergency department visits and an estimated $50 billion in healthcare costs annually. COPD includes conditions such as chronic bronchitis and emphysema. In 2022, 4.6% of adults in the U.S. were diagnosed with COPD.

Furthermore, the rising geriatric population, which is more susceptible to chronic diseases, is also expected to drive the demand for surgical procedures, thereby expanding the trocars market.

Risk of Complications

The risk of complications associated with trocar use is expected to be a significant restraint for the trocar market. Although trocars are designed to be safe, improper use or placement can lead to injury to surrounding tissues, such as blood vessels, organs, or nerves. These complications can result in additional surgical procedures, longer recovery times, and higher healthcare costs, all of which can deter hospitals and surgeons from adopting or increasing their use of trocars.

Segment Analysis

The global Trocars market is segmented based on product type, application, end-user, and region.

Product Type:

Disposable trocars segment is expected to dominate the global trocars market share

The disposable trocars segment is expected to dominate the trocars market due to several factors. These trocars are increasingly important in laparoscopic and diagnostic laparoscopy procedures. They are favored for their cost-effectiveness, user-friendliness, and enhanced safety compared to reusable options. Because they are disposable, each surgery can be set up quickly and easily while maintaining sterility, lowering the risk of infection, and requiring no reprocessing.

The convenience they offer, along with the elimination of sterilization needs and reduced risk of cross-contamination, further drives their growth. This aligns with the increasing focus on infection control measures and the rising demand for single-use surgical instruments.

Geographical Analysis

North America is expected to hold a significant position in the global trocars market share

North America's leading position in the trocars market is expected to continue, driven by several factors. The region boasts a strong healthcare system, significant healthcare spending, and a considerable presence of major companies in the field. North America has been quick to embrace advanced surgical technologies, with a growing trend towards minimally invasive procedures.

The rising rates of chronic conditions like cancer, lung diseases, diabetes, cardiovascular diseases, and obesity are also increasing the need for surgical interventions that utilize trocars. For instance, according to the National Institute of Health in 2023, primary spontaneous pneumothorax mainly occurs at 20-30 years of age. The incidence of PSP in the United States is 7 per 100,000 men and 1 per 100,000 women per year. Trocars are utilized in the treatment of primary spontaneous pneumothorax (PSP) during video-assisted thoracoscopic surgery (VATS). This data indicates a strong correlation between the increasing prevalence of lung diseases and the growth of the trocars market in North America.

Additionally, the strategic activities of market players, such as introducing new products, contribute to market growth in the region.

Competitive Landscape

The major global players in the trocars market include Conmed Corporation, The Cooper Companies Inc, Teleflex Incorporated, Medtronic Plc, B. Braun Medical Inc, JOHNSON & JOHNSON, Laprosurge, Purple Surgical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Peters Surgical among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Trocars Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Risk of Complications
    • 4.1.3. Opportunity
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Bladeless Trocars*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bladed Trocars
  • 6.4. Disposable Trocars
  • 6.5. Reusable Trocars
  • 6.6. Optical Trocars
  • 6.7. Blunt Trocars
  • 6.8. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. General Surgery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gynecological Surgery
  • 7.4. Urological Surgery
  • 7.5. Pediatric Surgery
  • 7.6. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Conmed Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. The Cooper Companies Inc
  • 11.3. Teleflex Incorporated
  • 11.4. Medtronic Plc
  • 11.5. B. Braun Medical Inc
  • 11.6. JOHNSON & JOHNSON
  • 11.7. Laprosurge
  • 11.8. Purple Surgical
  • 11.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 11.10. Peters Surgical
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us